Proqr Therapeutics N V (PRQR)

May 05, 2026

ProQR Sets June 2, 2026 Date for Annual General Meeting of Shareholders - The Globe and Mail

May 05, 2026

May 05, 2026

ProQR forms advisory board, partnership with Ginkgo as part of AI strategy - MSN

May 05, 2026

May 04, 2026

ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 - markets.businessinsider.com

May 04, 2026

May 04, 2026

ProQR Therapeutics NV expected to post a loss of 12 cents a shareEarnings Preview - TradingView

May 04, 2026

May 04, 2026

ProQR Therapeutics N : AGM 2026 POA Registered Shareholders - marketscreener.com

May 04, 2026

May 04, 2026

ProQR sets June 2 shareholder meeting, posts agenda documents online - Stock Titan

May 04, 2026

May 04, 2026

ProQR (PRQR) 2026 AGM to expand share capital, issuance and buyback powers - Stock Titan

May 04, 2026

May 03, 2026

MSN Money - MSN

May 03, 2026

May 01, 2026

ProQR Nominates Boehringer Ingelheim CMO Lykke Hinsch Gylvin to Board to Support Next Growth Phase - The Globe and Mail

May 01, 2026

Apr 30, 2026

ProQR nominates Boehringer Ingelheim executive to board - Investing.com UK

Apr 30, 2026

Apr 30, 2026

ProQR nominates Boehringer Ingelheim executive to board By Investing.com - Investing.com Australia

Apr 30, 2026

Apr 30, 2026

Boehringer exec tapped for ProQR (NASDAQ: PRQR) board nomination - Stock Titan

Apr 30, 2026

Apr 30, 2026

ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors - GlobeNewswire

Apr 30, 2026

Apr 29, 2026

ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Down 24.4% in April - MarketBeat

Apr 29, 2026

Apr 27, 2026

ProQR Therapeutics NV (MEX:PRQRN) Stock News, Headlines & Updates - GuruFocus

Apr 27, 2026

Apr 27, 2026

ProQR Therapeutics NV (MEX:PRQRN) Stock Price & 30 Year Financial Data - GuruFocus

Apr 27, 2026

Apr 27, 2026

Chardan Capital Maintains ProQR Therapeutics N.V. (PRQR) Buy Recommendation - MSN

Apr 27, 2026

Apr 26, 2026

ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Apr 26, 2026

Apr 25, 2026

ProQR Therapeutics (NASDAQ:PRQR) Stock Price Passes Above 50 Day Moving AverageShould You Sell? - MarketBeat

Apr 25, 2026

Apr 22, 2026

ProQR Therapeutics NV (MEX:PRQRN) Short-term investments - GuruFocus

Apr 22, 2026

Apr 18, 2026

ProQR Therapeutics Virtual Investor Event Transcript - GuruFocus

Apr 18, 2026

Apr 18, 2026

ProQR Therapeutics NV (MEX:PRQRN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Apr 18, 2026

Apr 16, 2026

Bart Filius Net Worth (2026) - GuruFocus

Apr 16, 2026

Apr 16, 2026

De Boer Daniel Anton Net Worth (2026) - GuruFocus

Apr 16, 2026

Apr 16, 2026

ProQR Therapeutics N.V. (PRQR) - Minichart

Apr 16, 2026

Apr 13, 2026

Jobs Data: Can ProQR Therapeutics NV withstand a market correctionQuarterly Investment Review & AI Based Buy and Sell Signals - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Stock Analysis: Can ProQR Therapeutics NV outperform under higher oil prices2026 Short Interest & Precise Trade Entry Recommendations - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Volume Report: Is ProQR Therapeutics NV currently under institutional pressure2026 Gainers & Expert Verified Movement Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

If You Invested $1,000 in Proqr Therapeuti (PRQR) - Stock Titan

Apr 11, 2026

Apr 10, 2026

ProQR Therapeutics: Waiting On Proof As AX-0810 Data Approaches (NASDAQ:PRQR) - Seeking Alpha

Apr 10, 2026

Apr 09, 2026

PRQR: Chardan Capital Maintains Buy Rating with $4.00 Price Targ - GuruFocus

Apr 09, 2026

Apr 09, 2026

Proqr Therapeutics expands early-stage pipeline - BioWorld News

Apr 09, 2026

Apr 09, 2026

ProQR Therapeutics (NASDAQ:PRQR) Earns "Buy" Rating from Chardan Capital - MarketBeat

Apr 09, 2026

Apr 09, 2026

ProQR Therapeutics Unveils New RNA Editing Programs; AX-0810 Phase 1 Target Data Due This Quarter - Defense World

Apr 09, 2026

Apr 09, 2026

Aberdeen Group Boosts Stake in ProQR Therapeutics - National Today

Apr 09, 2026

Apr 09, 2026

Aberdeen Group plc Has $5.96 Million Holdings in ProQR Therapeutics N.V. $PRQR - MarketBeat

Apr 09, 2026

Apr 09, 2026

ProQR Details Axiomer Pipeline Expansion and New Liver and Genetic Disease Programs - The Globe and Mail

Apr 09, 2026

Apr 08, 2026

ProQR (PRQR) Partners with Ginkgo Bioworks to Boost AI-Driven Dr - GuruFocus

Apr 08, 2026

Apr 08, 2026

ProQR partners with Ginkgo on AI drug discovery platform By Investing.com - Investing.com Australia

Apr 08, 2026

Apr 08, 2026

ProQR updates RNA editing pipeline, targets biliary atresia By Investing.com - Investing.com Australia

Apr 08, 2026

Apr 08, 2026

ProQR Forms AI Advisory Board and Partners with Ginkgo Bioworks - Intellectia AI

Apr 08, 2026

Apr 08, 2026

ProQR updates RNA editing pipeline, targets biliary atresia - Investing.com

Apr 08, 2026

Apr 08, 2026

Pipeline expansion and cash runway into 2027 for ProQR (PRQR) - Stock Titan

Apr 08, 2026

Apr 08, 2026

ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event - Weekly Voice

Apr 08, 2026

Apr 08, 2026

ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst CallSlideshow (NASDAQ:PRQR) 2026-04-08 - Seeking Alpha

Apr 08, 2026